Araştırma Makalesi

The Effect of ERCP on Mortality and Morbidity in Acute Pancreatitis

Cilt: 19 Sayı: 1 28 Nisan 2022
PDF İndir
EN TR

The Effect of ERCP on Mortality and Morbidity in Acute Pancreatitis

Öz

Background: Gallstones and biliary sludge are the most important causes of acute pancreatitis (AP) in our country. For many years, endoscopic retrograde cholangiopancreatography (ERCP) has been used to diagnose and treat acute biliary pancreatitis (ABP). The patient's treatment with acute biliary pancreatitis should be assessed in light of current international guidelines. This study aimed to analyze the patients who were admitted to our clinic with the diagnosis of acute biliary pancreatitis and underwent Endoscopic Retrograde Cholangiopancreatography (ERCP) for treatment, in the light of the literature.
Materials and Methods: The records of patients who underwent ERCP with a diagnosis of acute biliary pancreatitis in our general surgery endoscopy department between April 2020 and March 2021 were retrospectively reviewed.
Results: ERCP was performed in 131 patients with acute biliary pancreatitis. 60 (45.8%) of the patients were male, whereas 71 (54.2%) were female. ERCP was performed on 121 (92.36%) patients for common choledochal stones, 9 (6.87%) for periampullary/distal end of the choledochal tumor, and 1 (0.76%) for acute pancreatitis due to biliary tract rupture after hepatic cyst surgery. While 30 patients underwent ERCP, endoscopic sphincterotomy (ES), and the placement of a plastic stent in the common bile duct, 99 patients underwent ERCP, ES, and stone extraction from the common bile duct. There was no operative mortality.
Conclusions: Acute pancreatitis is a very heterogeneous disease, ranging from mild edematous pancreatitis to severe necrotizing pancreatitis with a mortality of 20%. There are still many controversial issues in the diagnosis and treat-ment of this disease. However, endoscopic retrograde cholangiopancreatography, a minimally invasive biliary pan-creatitis procedure, should be at the forefront of diagnosis and treatment.

Keywords: Acute biliary pancreatitis, Endoscopic retrograde cholangiopancreatography, choledocholithiasis

Anahtar Kelimeler

Destekleyen Kurum

yok

Proje Numarası

yok

Teşekkür

kızım Aybanu Uğurlu ya teşekkür ederim

Kaynakça

  1. 1. Acosta JM, Ledesma CL. Gallstone migration as a cause of acute pancreatitis. N Engl J Med 1974;290:484–487
  2. 2. Digestive Diseases and Sciences https://doi.org/10.1007/s10620-021-06905-7 EDITORIAL Overcoming Ductal Block: Emergency ERCP and Sphincterotomy Plus Common Bile Duct Stenting Improves Therapeutic Outcomes in Severe Gallstone Pancreatitis David Q. H. Wang1 · Piero Portincasa2 · Min Liu3 · Patrick Tso3
  3. 3. Gülten M. Endoscopic Retrograde Cholangiopancreatography in Acute Pancreatitis Turkiye Klinikleri J Gastroenterohepatol-Special Topics. 2014;7(3):104-8
  4. 4. Dönmez E, Sekizli M, Açıkgöz S.B, Sekizli H. Relationship between serum endocan levels and clinical follow-up in patients with acute pancreatitis: Can serum endocan be a biomarker for acute pancreatitis? The Turkish Journal of Academic Gastroenterology 2019;18:27-32.
  5. 5. Leppäniemi A, Tolonen M, Tarasconi A, et al. 2019 WSES guidelines for the management of severe acute pancreatitis. World J Emerg Surg. 2019;14:27
  6. 6. Van Geenen EJ, van der Peet DL, Bhagirath P, Mul¬der CJ, Bruno MJ. Etiology and diagnosis of acute biliary pancreatitis. Nat Rev Gastroenterol Hepatol 2010; 7: 495-502.
  7. 7. Van Erpecum KJ. Complications of bile duct stones: acute cholangitis and pancreatitis. Best Practice&Research Clinical Gastroenterology 2006; 20: 1139-52
  8. 8. Cotton, P.B. ERCP: risks, prevention, and management. In: Advanced Digestive Endoscopy Series: ERCP Section. Cotton, P.B.; Ed Charleston, S.C., USA: The Digestive Disease Center at the Medical University of South Carolina (MUSC). Edited by: Peter, B. Cotton and Joseph, W.C. Leung. Blackwell Pub, 2005; 13: 339 –404

Ayrıntılar

Birincil Dil

İngilizce

Konular

Klinik Tıp Bilimleri

Bölüm

Araştırma Makalesi

Yayımlanma Tarihi

28 Nisan 2022

Gönderilme Tarihi

22 Mart 2022

Kabul Tarihi

11 Nisan 2022

Yayımlandığı Sayı

Yıl 2022 Cilt: 19 Sayı: 1

Kaynak Göster

APA
Uğurlu, E. T., & Bilgi Kırmacı, M. (2022). The Effect of ERCP on Mortality and Morbidity in Acute Pancreatitis. Harran Üniversitesi Tıp Fakültesi Dergisi, 19(1), 110-115. https://doi.org/10.35440/hutfd.1091880
AMA
1.Uğurlu ET, Bilgi Kırmacı M. The Effect of ERCP on Mortality and Morbidity in Acute Pancreatitis. Harran Üniversitesi Tıp Fakültesi Dergisi. 2022;19(1):110-115. doi:10.35440/hutfd.1091880
Chicago
Uğurlu, Esat Taylan, ve Mehlika Bilgi Kırmacı. 2022. “The Effect of ERCP on Mortality and Morbidity in Acute Pancreatitis”. Harran Üniversitesi Tıp Fakültesi Dergisi 19 (1): 110-15. https://doi.org/10.35440/hutfd.1091880.
EndNote
Uğurlu ET, Bilgi Kırmacı M (01 Nisan 2022) The Effect of ERCP on Mortality and Morbidity in Acute Pancreatitis. Harran Üniversitesi Tıp Fakültesi Dergisi 19 1 110–115.
IEEE
[1]E. T. Uğurlu ve M. Bilgi Kırmacı, “The Effect of ERCP on Mortality and Morbidity in Acute Pancreatitis”, Harran Üniversitesi Tıp Fakültesi Dergisi, c. 19, sy 1, ss. 110–115, Nis. 2022, doi: 10.35440/hutfd.1091880.
ISNAD
Uğurlu, Esat Taylan - Bilgi Kırmacı, Mehlika. “The Effect of ERCP on Mortality and Morbidity in Acute Pancreatitis”. Harran Üniversitesi Tıp Fakültesi Dergisi 19/1 (01 Nisan 2022): 110-115. https://doi.org/10.35440/hutfd.1091880.
JAMA
1.Uğurlu ET, Bilgi Kırmacı M. The Effect of ERCP on Mortality and Morbidity in Acute Pancreatitis. Harran Üniversitesi Tıp Fakültesi Dergisi. 2022;19:110–115.
MLA
Uğurlu, Esat Taylan, ve Mehlika Bilgi Kırmacı. “The Effect of ERCP on Mortality and Morbidity in Acute Pancreatitis”. Harran Üniversitesi Tıp Fakültesi Dergisi, c. 19, sy 1, Nisan 2022, ss. 110-5, doi:10.35440/hutfd.1091880.
Vancouver
1.Esat Taylan Uğurlu, Mehlika Bilgi Kırmacı. The Effect of ERCP on Mortality and Morbidity in Acute Pancreatitis. Harran Üniversitesi Tıp Fakültesi Dergisi. 01 Nisan 2022;19(1):110-5. doi:10.35440/hutfd.1091880

Bu dergide yayınlanan makaleler Creative Commons Atıf-GayriTicari-AynıLisanslaPaylaş 4.0 (CC-BY-NC-SA 4.0) Uluslararası Lisansı ile lisanslanmıştır.